CACNG8
Basic information
Region (hg38): 19:53962937-53990215
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CACNG8 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 1 | 0 |
Variants in CACNG8
This is a list of pathogenic ClinVar variants found in the CACNG8 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-53963166-C-A | not specified | Uncertain significance (Mar 30, 2024) | ||
19-53963195-G-A | not specified | Uncertain significance (Jan 22, 2024) | ||
19-53963306-C-G | not specified | Uncertain significance (Feb 23, 2023) | ||
19-53963359-G-C | not specified | Uncertain significance (Oct 05, 2023) | ||
19-53963359-G-T | not specified | Likely benign (Feb 17, 2022) | ||
19-53979870-T-C | not specified | Uncertain significance (Jan 30, 2024) | ||
19-53979935-G-A | not specified | Uncertain significance (Dec 05, 2022) | ||
19-53979935-G-C | not specified | Uncertain significance (Jan 26, 2022) | ||
19-53979947-C-T | not specified | Uncertain significance (Jul 13, 2021) | ||
19-53982128-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
19-53982130-G-A | not specified | Uncertain significance (Nov 28, 2023) | ||
19-53982152-A-G | not specified | Uncertain significance (Dec 02, 2021) | ||
19-53982253-A-T | not specified | Uncertain significance (Sep 08, 2024) | ||
19-53982277-T-G | not specified | Uncertain significance (Feb 23, 2023) | ||
19-53982314-G-A | not specified | Uncertain significance (May 23, 2023) | ||
19-53982326-G-C | not specified | Uncertain significance (Jun 29, 2023) | ||
19-53982458-G-C | not specified | Uncertain significance (Jul 27, 2024) | ||
19-53982512-C-T | not specified | Uncertain significance (Jan 08, 2024) | ||
19-53982539-C-T | not specified | Uncertain significance (May 14, 2024) | ||
19-53982596-G-A | not specified | Uncertain significance (Jun 24, 2022) | ||
19-53982605-G-A | not specified | Uncertain significance (Feb 16, 2023) | ||
19-53982647-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
19-53982650-G-C | not specified | Uncertain significance (Dec 04, 2024) | ||
19-53982671-C-T | not specified | Uncertain significance (Mar 22, 2023) | ||
19-53982709-G-A | not specified | Uncertain significance (Apr 05, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CACNG8 | protein_coding | protein_coding | ENST00000270458 | 4 | 27176 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.964 | 0.0361 | 0 | 0 | 0 | 0 | 0.00 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.34 | 89 | 176 | 0.505 | 0.00000821 | 2664 |
Missense in Polyphen | 28 | 71.305 | 0.39268 | 887 | ||
Synonymous | -0.0503 | 83 | 82.4 | 1.01 | 0.00000402 | 966 |
Loss of Function | 2.98 | 0 | 10.3 | 0.00 | 4.54e-7 | 118 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00 | 0.00 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00 | 0.00 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Regulates the activity of L-type calcium channels that contain CACNA1C as pore-forming subunit (By similarity). Regulates the trafficking and gating properties of AMPA-selective glutamate receptors (AMPARs). Promotes their targeting to the cell membrane and synapses and modulates their gating properties by slowing their rates of activation, deactivation and desensitization and by mediating their resensitization. Does not show subunit-specific AMPA receptor regulation and regulates all AMPAR subunits. {ECO:0000250|UniProtKB:Q8VHW2, ECO:0000269|PubMed:20805473, ECO:0000269|PubMed:21172611}.;
- Pathway
- Oxytocin signaling pathway - Homo sapiens (human);Cardiac muscle contraction - Homo sapiens (human);Dilated cardiomyopathy (DCM) - Homo sapiens (human);Arrhythmogenic right ventricular cardiomyopathy (ARVC) - Homo sapiens (human);Hypertrophic cardiomyopathy (HCM) - Homo sapiens (human);Adrenergic signaling in cardiomyocytes - Homo sapiens (human);MAPK signaling pathway - Homo sapiens (human);Arrhythmogenic Right Ventricular Cardiomyopathy;MAPK Signaling Pathway;Developmental Biology;GPCR Dopamine D1like receptor;Neuronal System;Phase 0 - rapid depolarisation;Phase 2 - plateau phase;Cardiac conduction;Muscle contraction;Trafficking of AMPA receptors;Glutamate binding, activation of AMPA receptors and synaptic plasticity;Neurotransmitter receptors and postsynaptic signal transmission;Transmission across Chemical Synapses;LGI-ADAM interactions
(Consensus)
Haploinsufficiency Scores
- pHI
- 0.115
- hipred
- hipred_score
- ghis
- 0.662
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.180
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cacng8
- Phenotype
- growth/size/body region phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype;
Gene ontology
- Biological process
- calcium ion transport;transmission of nerve impulse;positive regulation of synaptic transmission, glutamatergic;calcium ion transmembrane transport;neurotransmitter receptor transport, postsynaptic endosome to lysosome;postsynaptic neurotransmitter receptor diffusion trapping;neurotransmitter receptor internalization;regulation of AMPA receptor activity
- Cellular component
- plasma membrane;voltage-gated calcium channel complex;postsynaptic density;cell junction;endocytic vesicle membrane;AMPA glutamate receptor complex;postsynaptic density membrane;L-type voltage-gated calcium channel complex
- Molecular function
- voltage-gated calcium channel activity;calcium channel regulator activity;channel regulator activity